Panagora Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Panagora Asset Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,974	Closed	-$347K	–	1627
2022 Q1	$347K	Sell	6,974 -1,532	-18%	-$79.4K	﹤0.01%	1326
2021 Q4	$642K	Buy	8,506 +4,513	+113%	+$308K	﹤0.01%	1111
2021 Q3	$315K	Sell	3,993 -3,915	-50%	-$394K	﹤0.01%	1495
2021 Q2	$1.1M	Sell	7,908 -567	-7%	-$108K	0.01%	941
2021 Q1	$1.77M	Buy	8,475 +1,962	+30%	+$393K	0.01%	781
2020 Q4	$1.08M	Buy	6,513 +693	+12%	+$107K	0.01%	941
2020 Q3	$989K	Buy	5,820 +5,262	+943%	+$759K	0.01%	903
2020 Q2	$93K	Buy	+558	New	+$87K	﹤0.01%	1809

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Panagora Asset Management's HARP Position: Q2 2022 in Review

Panagora Asset Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 6,974 shares — an estimated $347K sold.

Panagora Asset Management first reported a position in HARP in Q2 2020 and held it in 8 quarters. The position peaked at $1.77M in Q1 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

Panagora Asset Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Panagora Asset Management sold 6,974 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $347K.
Panagora Asset Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Panagora Asset Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.77M in Q1 2021.
63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.